Replies to post #15888 on Momenta Pharmaceuticals, Inc. (MNTA)

[t57]

Remind me
Does the FDA follow this close enough as a possible trigger for a conditional approval of Enox 40

[linhdtu]

12 is cheap I added today, especially with this patent ruling.

[DewDiligence]

MYL's PR on USPTO invalidation of the '302 patent:

http://finance.yahoo.com/news/mylan-invalidates-third-teva-copaxone-191200339.html